RJA
SKIN icon

Raymond James & Associates’s SkinHealth Systems SKIN Stock Holding History

Raymond James & Associates’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-552
Closed -$49K – 4074
2024
Q1 		$49K Buy
552
+50
+10% +$3.25K ﹤0.01% 3804
2023
Q4 		$31.2K Buy
+502
New +$37.7K ﹤0.01% 3743
2023
Q1 		– Sell
-2,338
Closed -$425K – 4050
2022
Q4 		$425K Sell
2,338
-1,231
-34% -$266K ﹤0.01% 3003
2022
Q3 		$841K Sell
3,569
-492
-12% -$124K ﹤0.01% 2515
2022
Q2 		$1.04M Buy
4,061
+766
+23% +$205K ﹤0.01% 2412
2022
Q1 		$1.11M Sell
3,295
-391
-11% -$129K ﹤0.01% 2517
2021
Q4 		$1.78M Sell
3,686
-148
-4% -$76.3K ﹤0.01% 2255
2021
Q3 		$1.99M Buy
3,834
+2,386
+165% +$1.05M ﹤0.01% 2110
2021
Q2 		$487K Buy
+1,448
New +$396K ﹤0.01% 3093

Other funds holding SKIN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCG
Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Raymond James & Associates's SKIN Position: Q2 2024 in Review

Raymond James & Associates sold out of SkinHealth Systems (SKIN) in Q2 2024, closing a stake of 552 shares — an estimated $49K sold.

Raymond James & Associates first reported a position in SKIN in Q2 2021 and held it in 9 quarters. The position peaked at $1.99M in Q3 2021. 116 funds tracked by Wall St. Rank hold SKIN as of Q2 2024.

  • Raymond James & Associates reported no remaining SkinHealth Systems position as of Q2 2024 after selling out during the quarter.
  • Raymond James & Associates sold 552 SkinHealth Systems shares in Q2 2024, an estimated $49K.
  • Raymond James & Associates first reported a position in SkinHealth Systems in Q2 2021 and held it in 9 quarters.
  • Raymond James & Associates's SkinHealth Systems position peaked at $1.99M in Q3 2021.
  • 116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2024.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.